Skip to main content

Fondaparinux use while Breastfeeding

Medically reviewed by Drugs.com. Last updated on Jan 23, 2024.

Drugs containing Fondaparinux: Arixtra, Arixtra 7.5 mg/dose, Arixtra 5 mg/dose, Arixtra 10 mg/dose

Fondaparinux Levels and Effects while Breastfeeding

Summary of Use during Lactation

Fondaparinux is considered to be acceptable to use during breastfeeding.[1]

Drug Levels

Maternal Levels. Relevant published information was not found as of the revision date.

Infant Levels. Relevant published information was not found as of the revision date.

Effects in Breastfed Infants

Relevant published information was not found as of the revision date.

Effects on Lactation and Breastmilk

Relevant published information was not found as of the revision date.

Alternate Drugs to Consider

Acenocoumarol, Dalteparin, Enoxaparin, Heparin, Rivaroxaban, Warfarin

References

1.
Bates SM, Rajasekhar A, Middeldorp S, et al. American Society of Hematology 2018 guidelines for management of venous thromboembolism: Venous thromboembolism in the context of pregnancy. Blood Adv. 2018;2:3317–59. [PMC free article: PMC6258928] [PubMed: 30482767]

Substance Identification

Substance Name

Fondaparinux

CAS Registry Number

114870-03-0

Drug Class

Breast Feeding

Lactation

Anticoagulants

Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer